External beam radiotherapy of recurrent glioma: Radiation tolerance of the human brain

Cancers

Volumn 4, Issue 2, 2012, Pages 379-399

  Sminia, Peter ^a   Mayer, Ramona ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EBG MedAustron GmbH   (Austria)

Author keywords

Brain; Equivalent total dose (EQD2); Glioma; Late side effects; Re irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; LOMUSTINE; PACLITAXEL; TEMOZOLOMIDE;

ASTROCYTOMA; BLOOD TOXICITY; BRAIN NECROSIS; COGNITIVE DEFECT; DEEP VEIN THROMBOSIS; EDEMA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; GLIOBLASTOMA; GLIOMA; HEADACHE; HUMAN; HYPERTENSION; INTESTINE PERFORATION; INTRACRANIAL HYPERTENSION; LINEAR ACCELERATOR; NEUROTOXICITY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RECURRENT CANCER; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; THROMBOCYTOPENIA; TUMOR BLEEDING; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

EID: 84862678207     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers4020379     Document Type: Review

References (55)

1. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987-996.
2. Stupp, R.; Hegi, M.E.; Mason, W.P.; van den Bent, M.J.; Taphoorn, M.J.; Janzer, R.C.; Ludwin, S.K.; Allgeier, A.; Fisher, B.; Belanger, K.; et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10, 459-466.
3. Jansen, E.P.; Dewit, L.G.; van Herk, M.; Bartelink, H. Target volumes in radiotherapy for high grade malignant glioma of the brain. Radiother. Oncol. 2000, 56, 151-156.
4. Emami, B.; Lyman, J.; Brown, A.; Coia, L.; Goitein, M.; Munzenrider, J.E.; Shank, B.; Solin, L.J.; Wesson, M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1991, 21, 109-122.
5. Lawrence, Y.R.; Li, X.A.; El Naqa, I.; Hahn, C.A.; Marks, L.B.; Merchant, T.E.; Dicker, A.P. Radiation dose-volume effects in the brain. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76, S20-S27.
6. Barendsen, G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8, 1981-1997.
7. Joiner, M.C.; Bentzen, S.M. Fractionation: The linear-quadratic approach. In Basic Clinical Radiobiology; Joiner, M.C., van der Kogel, A.J., Eds.; Hodder Arnold: London, UK, 2009; pp. 102-119.
8. Shrieve, D.C. Radiation dose, fractionation and normal tissue injury. In Human Radiation Injury; Shrieve, D.C., Loeffler, J.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2011; pp. 32-42.
9. Kim, H.K.; Thornton, A.F.; Greenberg, H.S.; Page, M.A.; Junck, L.; Sandler, H.M. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am. J. Clin. Oncol. 1997, 20, 358-363.
10. Hayat, K.; Jones, B.; Bisbrown, G.; Baria, K.; Pigott, T. Retreatment of patients with intracranial gliomas by external beam radiotherapy and cytotoxic chemotherapy. Clin. Oncol.1997, 9, 158-163.
11. Arcicasa, M.; Roncadin, M.; Bidoli, E.; Dedkov, A.; Gigante, M.; Trovò, M.G. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 1999, 43, 789-793
12. Nieder, C.; Nestle, U.; Niewald, M.; Walter, K.; Schnabel, K. Hyperfractionated reirradiation for malignant gliomas. Front. Radiat. Ther. Oncol. 1999, 33, 150-157.
13. Veninga, T.; Langendijk, H.A.; Slotman, B.J.; Rutten, E.H.; van der Kogel, A.J.; Prick, M.J.; Keyser, A.; van der Maazen, R.W. Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors. Radiother. Oncol. 2001, 59, 127-137.
14. Henke, G.; Paulsen, F.; Steinbach, J.P.; Ganswindt, U.; Isijanov, H.; Kortmann, R.D.; Bamberg, M.; Belka, C. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther. Onkol. 2009, 185, 113-119.
15. Niyazi, M.; Ganswindt, U.; Schwarz, S.B.; Kreth, F.W.; Tonn, J.C.; Geisler, J.; la Fougère, C.; Ertl, L.; Linn, J.; Siefert, A.; et al. Irradiation and bevacizumab in high-grade glioma retreatment settings. Int. J. Radiat. Oncol. Biol. Phys. 2011, 98, 1-14.
16. Shepherd, S.F.; Laing, R.W.; Cosgrove, V.P.; Warrington, A.P.; Hines, F.; Ashley, S.E.; Brada, M. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37, 393-398.
17. Cho, K.H.; Hall, W.A.; Gerbi, B.J.; Higgins, P.D.; McGuire, W.A.; Clark, H.B. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45, 1133-1141.
18. Hudes, R.S.; Corn, B.W.; Werner-Wasik, M.; Andrews, D.; Rosenstock, J.; Thoron, L.; Downes, B.; Curran, W.J., Jr. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 1999, 43, 293-298.
19. Lederman, G.; Wronski, M.; Arbit, E.; Odaimi, M.; Wertheim, S.; Lombardi, E.; Wrzolek, M. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am. J. Clin. Oncol. 2000, 23, 155-159.
20. Voynov, G.; Kaufman, S.; Hong, T.; Pinkerton, A.; Simon, R.; Dowsett, R. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am. J. Clin. Oncol. 2002, 25, 606-611.
21. Grosu, A.L.; Weber, W.A.; Franz, M.; Stärk, S.; Piert, M.; Thamm, R.; Gumprecht, H.; Schwaiger, M.; Molls, M.; Nieder, C. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63, 511-519.
22. Vordermark, D.; Kolbl, O.; Ruprecht, K.; Vince, G.H.; Bratengeier, K.; Flentje, M. Hypofractionated stereotactic re-irradiation: Treatment option in recurrent malignant glioma. BMC Cancer 2005, 5, 55.
23. Ernst-Stecken, A.; Ganslandt, O.; Lambrecht, U.; Sauer, R.; Grabenbauer, G. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J. Neurooncol. 2007, 81, 287-294.
24. Kohshi, K.; Yamamoto, H.; Nakahara, A.; Katoh, T.; Takagi, M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J. Neurooncol. 2007, 82, 297-303.
25. Laing, R.W.; Warrington, A.P.; Graham, J.; Britton, J.; Hines, F.; Brada, M. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother. Oncol. 1993, 27, 22-29.
26. Combs, S.E.; Thilmann, C.; Edler L.; Debus, J.; Schulz-Ertner, D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients in a single insitution. J. Clin. Oncol. 2005, 23, 8863-8869.
27. Fokas, E.; Wacker, U.; Gross, M.W.; Henzel, M.; Encheva, E.; Engenhart-Cabillic, R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: A beneficial treatment option after high-dose radiotherapy? Strahlenther. Onkol. 2009, 185, 235-240.
28. Gutin, P.H.; Iwamoto, F.M.; Beal, K.; Mohile, N.A.; Karimi, S.; Hou, B.L.; Lymberis, S.; Yamada, Y.; Chang, J.; Abrey, L.E. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 156-163.
29. Fogh, S.E.; Andrews, D.W.; Glass, J.; Curran, W.; Glass, C.; Champ, C.; Evans, J.J.; Hyslop, T.; Pequignot, E.; Downes, B.; et al. Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas. J. Clin. Oncol. 2010, 28, 3048-3053.
30. Minniti, G.; Armosini, V.; Salvati, M.; Lanzetta, G.; Caporello, P.; Mei, M.; Osti, M.F.; Maurizi, R.E. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J. Neurooncol. 2011, 103, 683-691.
31. Patel, M.; Siddiqui, F.; Jin, J.Y.; Mikkelsen, T.; Rosenblum, M.; Movsas, B.; Ryu, S. Salvage reirradiation for recurrent glioblastoma with radiosurgery: Radiographic response and improved survival. J. Neurooncol. 2009, 92, 185-191.
32. Chamberlain, M.C.; Barba, D.; Kormanik, P.; Shea, W.M. Stereotactic radiosurgery for recurrent gliomas. Cancer 1994, 74, 1342-1347.
33. van Kampen, M.; Engenhart-Cabillic, R.; Debus, J.; Fuss, M.; Rhein, B.; Wannenmacher, M. The radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature. Strahlenther. Onkol. 1998, 174, 19-24.
34. Combs, S.E.; Widmer, V.; Thilmann, C.; Hof, H.; Debus, J.; Schulz-Ertner, D. Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005, 104, 2168-2173.
35. Biswas, T.; Okunieff, P.; Schell, M.C.; Smudzin, T.; Pilcher, W.H.; Bakos, R.S.; Vates, G.E.; Walter, K.A.; Wensel, A.; Korones, D.N.; et al. Stereotactic radiosurgery for glioblastoma: Retrospective analysis. Radiat. Oncol. 2009, 4, 11.
36. Pouratian, N.; Crowley, R.W.; Sherman, J.H.; Jagannathan, J.; Sheehan, J.P. Gamma knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma. J. Neurooncol. 2009, 94, 409-418.
37. Brenner, D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 2008, 18, 234-239.
38. Kirkpatrick, J.P.; Meyer, J.J.; Marks, L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin. Radiat. Oncol. 2008, 18, 240-243.
39. Bentzen, S.M.; Saunders, M.I.; Dische, S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother. Oncol. 1999, 53, 219-226.
40. Mayer, R.; Sminia, P. Reirradiation tolerance of the human brain. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70, 1350-1360.
41. Sahgal, A.; Wong, C.; van der Kogel, A.J. Spinal cord. In Human Radiation Injury; Shrieve, D.C., Loeffler, J.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2011; pp. 225-235.
42. Sminia, P.; Oldenburger, F.; Slotman, B.J.; Schneider, C.J.; Hulshof, M.C. Re-irradiation of the human spinal cord. Strahlenther. Onkol. 2002, 178, 453-456.
43. Fokas, E.; Kraft, G.; An, H.; Engenhart-Cabillic, R. Ion beam radiobiology and cancer: Time to update ourselves. Biochim. Biophys. Acta 2009, 1796, 216-229.
44. Suit, H.; Delaney, T.; Goldberg, S.; Paganetti, H.; Clasie, B.; Gerweck, L.; Niemierko, A.; Hall, E.; Flanz, J.; Hallman, J.; et al. Proton versus carbon ion beams in the definitive radiation treatment of cancer patients. Radiother. Oncol. 2010, 95, 3-22.
45. Schulz-Ertner, D.; Tsujii, H. Particle radiation therapy using proton and heavier ion beams. J. Clin. Oncol. 2007, 25, 953-964.
46. Combs, S.; Burkholder, I.; Edler, L.; Rieken, S.; Habermehl, D.; Jäkel, O.; Haberer, T.; Haselmann, R.; Unterberg, A.; Wick, W.; et al. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial. BMC Cancer 2010, 10, 533.
47. Laack, N.N.I.; Brown, P.D. Cognitive sequelae of brain radiation. In Human Radiation Injury; Shrieve, D.C., Loeffler, J.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2011; pp. 169-179.
48. Chakravarti, A.; Erkkinen, M.G.; Nestler, U.; Stupp, R.; Mehta, M.; Aldape, K.; Gilbert, M.R.; Black, P.M.; Loeffler, J.S. Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms. Clin. Cancer Res. 2006, 12, 4738-4746.
49. van Nifterik, K.A.; van den Berg, J.; Stalpers, L.J.; Lafleur, M.V.; Leenstra, S.; Slotman, B.J.; Hulsebos, T.J.; Sminia, P. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69, 1246-1253.
50. Chalmers, A.J.; Ruff, E.M.; Martindale, C.; Lovegrove, N.; Short, S.C. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 1511-1519.
51. PubMed Homepage. Available online: http://www.ncbi.nlm.nih.gov/pubmed/ (accessed on 2 March 2012).
52. Flickinger, J.C.; Kondziolka, D.; Lunsford, L.D.; Kassam, A.; Phuong, L.K.; Liscak, R.; Pollock, B. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46, 1143-1148.
53. Barani, I.J.; Sneed, P.K. Cerebral radionecrosis. In Human Radiation Injury; Shrieve, D.C., Loeffler, J.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2011; pp. 254-267.
54. Siepmann, D.B.; Siegel, A.; Lewis, P.J. Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis. Clin. Nucl. Med. 2005, 30, 199-200.
55. Wigg, R.W. Applied Radiobiology and Bioeffect Planning; Medical Physics Publishing Madison: Madison, WI, USA, 2001; p. 253.